These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19967742)

  • 21. Generation and genetic modification of induced pluripotent stem cells.
    Schambach A; Cantz T; Baum C; Cathomen T
    Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
    Hotta A; Ellis J
    J Cell Biochem; 2008 Nov; 105(4):940-8. PubMed ID: 18773452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review: Stem cells and gene therapy.
    Alenzi FQ; Lotfy M; Tamimi WG; Wyse RK
    Lab Hematol; 2010 Sep; 16(3):53-73. PubMed ID: 20858588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
    Trosko JE; Chang CC
    Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
    Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
    Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
    Kanawaty A; Henderson J
    Bioessays; 2009 Feb; 31(2):134-8. PubMed ID: 19204985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney repair using stem cells: myth or reality as a therapeutic option?
    Iwatani H; Imai E
    J Nephrol; 2010; 23(2):143-6. PubMed ID: 20175054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of parthenogenetic induced pluripotent stem cells from parthenogenetic neural stem cells.
    Do JT; Joo JY; Han DW; Araúzo-Bravo MJ; Kim MJ; Greber B; Zaehres H; Sobek-Klocke I; Chung HM; Schöler HR
    Stem Cells; 2009 Dec; 27(12):2962-8. PubMed ID: 19816953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of human-induced pluripotent stem cells.
    Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
    Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomere rejuvenation during nuclear reprogramming.
    Marión RM; Blasco MA
    Curr Opin Genet Dev; 2010 Apr; 20(2):190-6. PubMed ID: 20176474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human-induced pluripotent stem cells: derivation, propagation, and freezing in serum- and feeder layer-free culture conditions.
    Baharvand H; Totonchi M; Taei A; Seifinejad A; Aghdami N; Salekdeh GH
    Methods Mol Biol; 2010; 584():425-43. PubMed ID: 19907991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multilineage differentiation potential of human dermal skin-derived fibroblasts.
    Lorenz K; Sicker M; Schmelzer E; Rupf T; Salvetter J; Schulz-Siegmund M; Bader A
    Exp Dermatol; 2008 Nov; 17(11):925-32. PubMed ID: 18557932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful generation of donor specific hematopoietic stem cell lines from co-cultured bone marrow with human embryonic stem cell line: a new methodology.
    Vanikar AV; Mishra VV; Firoz A; Shah VR; Dave SD; Patel RD; Kanodia KV; Patel JV; Patel CN; Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):658-61. PubMed ID: 17445567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commitment of stem cells into functional hepatocytes.
    Ochiya T; Yamamoto Y; Banas A
    Differentiation; 2010 Feb; 79(2):65-73. PubMed ID: 19883970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation tolerance in an age of induced pluripotency.
    Fairchild PJ
    Curr Opin Organ Transplant; 2009 Aug; 14(4):321-5. PubMed ID: 19542888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells.
    Onorati M; Camnasio S; Binetti M; Jung CB; Moretti A; Cattaneo E
    Mol Cell Neurosci; 2010 Mar; 43(3):287-95. PubMed ID: 20026276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult reserve stem cells and their potential for tissue engineering.
    Young HE; Duplaa C; Romero-Ramos M; Chesselet MF; Vourc'h P; Yost MJ; Ericson K; Terracio L; Asahara T; Masuda H; Tamura-Ninomiya S; Detmer K; Bray RA; Steele TA; Hixson D; el-Kalay M; Tobin BW; Russ RD; Horst MN; Floyd JA; Henson NL; Hawkins KC; Groom J; Parikh A; Blake L; Bland LJ; Thompson AJ; Kirincich A; Moreau C; Hudson J; Bowyer FP; Lin TJ; Black AC
    Cell Biochem Biophys; 2004; 40(1):1-80. PubMed ID: 14983110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors.
    Niwa A; Umeda K; Chang H; Saito M; Okita K; Takahashi K; Nakagawa M; Yamanaka S; Nakahata T; Heike T
    J Cell Physiol; 2009 Nov; 221(2):367-77. PubMed ID: 19562687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.